AI patient monitoring in healthcare is subject to strict privacy and security requirements based on European and national legislation, supplemented by sector-specific standards such as ISO 27001 and NEN 7510. Healthcare organizations deploying AI monitoring software must comply with the GDPR, the EU AI Act, and additional requirements around data security and patient consent. The questions below answer the most frequently asked questions about compliance, privacy, and security in AI monitoring in healthcare practice.
Which legislation applies to AI monitoring in healthcare?
AI patient monitoring in healthcare falls under the General Data Protection Regulation (GDPR), the European AI Act, and national legislation such as the Medical Treatment Agreement Act (WGBO). Together, these laws determine how patients’ personal data may be processed, what risk classification an AI system receives, and what rights patients have.
The GDPR is the foundation: all personal data, including images of patients, is considered sensitive data requiring a high level of protection. Healthcare organizations must have a legal basis for processing, conclude a data processing agreement with technology suppliers, and conduct a Data Protection Impact Assessment (DPIA) before deploying AI monitoring.
The EU AI Act, which is being phased in, classifies AI systems in healthcare as high-risk. This means that suppliers must comply with requirements around transparency, robustness, human oversight, and technical documentation. Healthcare organizations deploying high-risk AI systems share responsibility for compliance with these requirements.
The WGBO regulates patients’ rights in the treatment relationship, including the right to information and the right to access data. This has direct implications for how healthcare institutions inform patients about the use of AI monitoring.
Which security standards apply specifically to healthcare technology?
Two central security standards apply to healthcare technology: ISO 27001 and NEN 7510. ISO 27001 is the international standard for information security and describes a management system for the structural protection of data. NEN 7510 is the Dutch implementation of this standard, specifically applied to the healthcare sector.
NEN 7510 translates the general principles of ISO 27001 into healthcare practice. The standard sets requirements for access management, data encryption, incident management, and the security of medical information systems. For healthcare organizations working with AI monitoring software, compliance with NEN 7510 is de facto mandatory in the Netherlands.
In addition to these two standards, NEN 7512 (reliability levels for data exchange) and NEN 7513 (logging of access to medical records) are also relevant. Together they form the normative framework within which healthcare technology can be deployed safely and responsibly. Suppliers that demonstrably comply with these standards give healthcare purchasers the assurance that patient data is structurally protected.
How is patient privacy protected in AI video surveillance?
In AI video surveillance in healthcare, patient privacy is protected by technical measures that ensure images are processed exclusively by the AI and never viewed by humans. The software analyzes images locally and only sends an alert when an unsafe situation is detected.
This principle, whereby human access to footage is structurally prevented, is one of the most effective privacy safeguards in AI monitoring. Healthcare staff only need to enter a patient’s room when the software requests it. This not only limits the infringement on the patient’s personal privacy, but also reduces unnecessary disruption of nighttime rest.
Other technical privacy measures include encryption of data transfers, strict access control to the system, and minimizing the amount of stored data. Organizationally, a healthcare institution must record who has access to alerts and log files, how long data is retained, and how incidents are reported to the Data Protection Authority.
When is patient consent required for AI monitoring?
Patient consent is required when there is no other legal basis for the processing of personal data via AI monitoring. In healthcare, the most commonly used legal bases are vital interest (in cases of acute safety risks) and legitimate interest, but consent remains in many cases the most transparent and patient-centered choice.
The GDPR states that consent must be freely given, specific, informed, and unambiguous. In the healthcare setting, this is a point of attention: patients or residents must not feel that they have no choice. If a healthcare institution introduces AI monitoring as a standard measure, it must clearly substantiate the legal basis on which it does so and how it informs patients about this.
For patients who lack mental capacity, such as people with advanced dementia, the legal representative gives consent on behalf of the patient. Healthcare organizations are advised to document this process in writing and embed it in their policy on AI monitoring.
How do healthcare purchasers assess the compliance of an AI supplier?
Healthcare purchasers assess the compliance of an AI supplier based on certifications, documentation, and the degree to which the supplier provides transparency about its data processing practices. The presence of ISO 27001 and NEN 7510 certification is a minimum requirement for serious procurement procedures.
During a procurement process, healthcare institutions typically request the following documents and information:
- A data processing agreement that complies with the GDPR
- Proof of ISO 27001 and/or NEN 7510 certification
- Technical documentation on data storage, encryption, and access management
- A description of the incident management process and reporting obligations
- Information on the location of data storage (within or outside the EU)
- DPIA support or a template for the healthcare institution
In addition to documentation, healthcare purchasers are increasingly looking at the patent portfolio and technical robustness of the AI solution. A supplier with demonstrable investments in reliability, such as a low rate of false alarms, gives purchasers greater confidence in the quality and safety of the system in practice.
How we help with safe and privacy-compliant AI patient monitoring
We understand that compliance is not a secondary concern for healthcare institutions, but a prerequisite for the responsible deployment of AI monitoring. Our solutions are therefore designed from the ground up with privacy and security at their core:
- No human access to images: All image processing is carried out by the AI. Healthcare staff do not see camera footage, but only receive an alert when the software detects an unsafe situation.
- ISO 27001 and NEN 7510 certified: We comply with the international and Dutch security standards for healthcare technology.
- 21 international patents: Our robust patent portfolio underlines the technical uniqueness and reliability of our AI solutions.
- Exceptionally low error rate: Our software generates only one false alarm every 92 days, ensuring reliable monitoring without unnecessary disruption.
- Plug-and-play implementation: Easy to plan, configure, and install, so your organization can get started compliantly without delay.
Would you like to know how we can support your healthcare organization with safe and privacy-compliant patient monitoring? Discover our AI monitoring solutions and contact us for a no-obligation conversation.
Frequently Asked Questions
What is a DPIA and when is it required for AI monitoring in healthcare?
A Data Protection Impact Assessment (DPIA) is a mandatory risk analysis that healthcare institutions must carry out before deploying AI monitoring software that processes personal data. Because AI video surveillance of patients is considered high-risk processing under the GDPR, a DPIA is required in virtually all cases. The DPIA identifies privacy risks and describes what measures are taken to manage those risks. Many suppliers offer a DPIA template or support to facilitate this process.
What are the consequences if a healthcare institution fails to comply with the GDPR or AI Act when using AI monitoring?
For non-compliance with the GDPR, the Data Protection Authority (DPA) can impose fines of up to 20 million euros or 4% of global annual turnover, whichever is higher. Under the EU AI Act, additional sanctions may follow for deploying non-compliant high-risk AI systems, including mandatory withdrawal from the market. Beyond financial risks, non-compliance can lead to reputational damage and loss of patient trust. It is therefore essential to have compliance fully in order before implementation.
How long may data from AI patient monitoring be retained?
The retention period for data from AI patient monitoring must be recorded in the healthcare institution’s privacy policy and should be as short as possible in accordance with the data minimization principle of the GDPR. For medical data, the WGBO generally stipulates a retention period of 20 years, but AI monitoring data often consists of alerts and log files for which shorter periods are appropriate. Healthcare institutions must establish a substantiated retention period for each type of data and document this in writing. Discuss this with your supplier as well, who can adjust technical settings to support automatic deletion.
How do I inform patients and their families in an understandable way about the use of AI monitoring?
Patients and their representatives must be informed in clear, non-legal language about what AI monitoring entails, what data is processed, who has access to alerts, and how long data is retained. This can be done via an information brochure, a conversation at admission, or a digital information environment. Emphasize that healthcare staff do not see camera footage and that the technology actually protects privacy by preventing unnecessary check rounds. Transparent communication increases the trust of patients and representatives and lowers the threshold for giving consent.
May AI monitoring software store data outside the European Union?
No, or at least not without additional legal safeguards. Under the GDPR, the transfer of personal data to countries outside the EU is only permitted if there is an adequacy decision, standard contractual clauses (SCCs), or other approved transfer mechanisms. For healthcare institutions, it is strongly advisable to choose suppliers that store and process data exclusively within the EU, as this significantly simplifies compliance. Always explicitly ask your supplier about the location of data storage and record this in the data processing agreement.
What role does the Data Protection Officer (DPO) play in the introduction of AI monitoring?
The Data Protection Officer (DPO) plays a central role in the introduction of AI monitoring in healthcare institutions that are required to appoint a DPO, such as hospitals and large healthcare organizations. The DPO advises on the lawfulness of data processing, reviews the DPIA, and oversees compliance with the GDPR throughout the entire duration of the project. It is advisable to involve the DPO at an early stage, already during the supplier selection phase, so that privacy requirements are directly incorporated into the procurement decision. A well-informed DPO can also assist with communication to patients and supervisory authorities.
How do I implement GDPR-compliant AI monitoring step by step?
Start by mapping the processing activities that the AI monitoring software carries out and determine the legal basis on which you base these. Then conduct a DPIA, conclude a data processing agreement with the supplier, and verify that the supplier holds the required certifications such as ISO 27001 and NEN 7510. Establish internal policies on access management, retention periods, and incident reporting, and ensure clear information provision to patients and their representatives. Involve your DPO and legal advisor in a timely manner to avoid delays at go-live.
Related Articles
- What can you as an employer do to reduce workload?
- How do other countries deal with staff shortages?
- How do you evaluate different fall prevention for elderly suppliers?
- Why is continuous monitoring a key to future-proof care?
This content was generated with the help of AI and it may contain mistakes